Hers review: the pill price excludes the membership

Combine two bills before comparing

The page lists a starting $149 medication figure for Wegovy pill, alongside a membership advertised at $39 for the first month and $149 afterward. Reading only the medication number would understate the described recurring arrangement. Any comparison should identify the actual pill offer, the membership term and other applicable costs rather than displaying a single attractive number without its unit.

Sources: Weight Loss Care for Women, Built to Last | Hers

The medicine name matters

A branded Wegovy tablet listing is not the same as an oral compounded liquid or another company’s compounded pill. The manufacturer page identifies Wegovy as a prescription product, with specific uses and warnings. A preference for a pill does not establish medical suitability. The prescriber should explain which preparation is selected and why it fits the individual clinical circumstances.

Sources: Weight Loss Care for Women, Built to Last | Hers

For another purchase structure, read Ro and Noom Med. These links compare the offers, not individual health outcomes.

A drug trial is not a Hers cohort

Hers cites oral-drug weight-loss information over a defined trial period. Those findings concern the studied medicine and participants, not a randomized evaluation of the Hers care platform. The page does not make the service’s convenience equivalent to trial enrollment. We have not obtained an individual prescription, verified outcomes or assessed whether a new customer matches the trial population.

Sources: Weight Loss Care for Women, Built to Last | Hers

Support and geography need exact scope

Hers advertises provider messaging and optional tracking features, while acknowledging geographic limitations. A connected scale is not an automatic condition of every prescription, and a national website does not mean every offer is available in every state. Someone comparing access should clarify the selected plan’s clinical contact, state availability and membership cancellation terms before relying on general platform promises.

Sources: Weight Loss Care for Women, Built to Last | Hers

Keep the full cost calculation and branded-versus-compounded distinction visible. Our evidence guide explains why different result types cannot be scored as one clinical ranking.

Keep the clinical question separate

NIDDK explains that prescription weight-management treatment is intended for people with relevant health circumstances and requires a professional assessment. A convenient website does not determine that assessment. This article cannot decide whether treatment is appropriate for a reader, compare individual risks or forecast weight change. The clinician needs the actual medical history and should explain the selected product and follow-up plan.

Sources: Prescription Medications to Treat Overweight & Obesity - NIDDK

Where this review ends

This review was written from official public pages available on October 1, 2026. We did not receive patient care, test medication, inspect a pharmacy or verify a completed purchase. Prices and program descriptions can change. FDA’s warning about unapproved GLP-1 products explains a regulatory distinction; it is not independent validation of this particular provider or product. Individual benefits, risks and eligibility require a qualified clinician.

Sources: FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss